Action Mechanism of Linggui Zhugan Decoction for the Treatment of Heart Failure Based on Network Pharmacology
【Abstract】Objective: To explore the potential targets of Linggui Zhugan Decoction for the treatment of heart failure by using network pharmacology. Methods: A bioinformatics analysis website for traditional Chinese medicine (BATMAN-TCM) was used to predict and screen the possible active components of Linggui Zhugan Decoction in the intervention of heart failure and its targets for heart failure. The Cytoscape software was used to construct a target-component network for the treatment of heart failure with Linggui Zhugan Decoction and its single medicines. Venn diagram (Venny 2.1) was used to further study the mechanism of Poria and Radix et Rhizoma Glycyrrhizae of Linggui Zhugan Decoction in the treatment of heart failure. Results: A total of 79 active components in the Linggui Zhugan Decoction were screened out from the results. There were 18 targets associated with heart failure, and the active components and targets were closely related. The 18 targets obtained mainly included: ACE; ADRA2 A; ADRA2 B and so on. The target number of Radix et Rhizoma Glycyrrhizae in Linggui Zhugan Decoction was the largest that it accounted for 94.4%of the total targets of the decoction in the treatment for heart failure. Conclusion: The mechanism of Linggui Zhugan Decoction in improving heart failure may be related to the decrease of Ang II, the inhibition of RAS activity, and the regulation of sympathetic nervous system, etc. Among which, Radix et Rhizoma Glycyrrhizae is the most prominent in the aspect of Linggui Zhugan Decoction in treating heart failure.
【Keywords】 Linggui Zhugan Decoction; Network pharmacology; Poria; Radix et Rhizoma Glycyrrhizae; Heart failure; Target;
 Zhang Y, Du WX, Zhang SQ, et al. Research progress of Linggui Zhugan Decoction in the treatment of diseases of the cardiovascular system [J]. Journal of Liaoning University of Traditional Chinese Medicine, 2016, 18 (2): 222–224 (in Chinese).
 Zhang YT. 苓桂术甘汤治疗慢性心力衰竭的临床观察 [J]. Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease, 2013, 11 (6): 661–662 (in Chinese).
 Yang C, Li XP, Wei SJ, et al. Impact of inflammatory cytokines, immune function and cardiac functional of Linggui Zhugan Decoction combined with western medicine for patients with chronic heart failure [J]. Chinese Journal of Immunology, 2018, 34 (7): 1 001–1 005 (in Chinese).
 Wang SM, Tian XL. 苓桂术甘汤加减联合西药治疗慢性心力衰竭的疗效及对心功能的影响 [J]. Chinese Journal of Critical Care Medicine, 2016, 36 (s1): 125–126 (in Chinese).
 Liu RH. 苓桂术甘汤加减联合西药改善慢性心力衰竭患者心功能临床疗效分析 [J].Chinese Journal of Modern Drug Application, 2016, 10 (5): 174–175 (in Chinese).
 Pei GX. Thirty-two cases of chronic heart failure in the elderly treated with modified poria and cinnamon twig and atractylodes macrocephala and licorice decoction [J]. Henan Traditional Chinese Medicine, 2018, 38 (3): 350–352 (in Chinese).
 Chen SX, Liang XY, Hou XL. Clinical observation on modified Linggui Zhugan Formula granule in treating heart failure with reduced left ventricular ejection fraction [J]. Guangming Journal of Chinese Medicine, 2018, 33 (8): 1 104–1 107 (in Chinese).
 Shi H, Wang L, Xu S, et al. Effect of Linggui Zhugan Decoction containing serum on protein expression of IKK/IkB/NF-kB signal pathways in lipopolysaccharide-induced cardiomyocyte injury model rats [J]. Chinese Journal of Integrated Traditional and Western Medicine, 2017, 37 (10): 1 215–1 219 (in Chinese).
 Fang HY, Huang JL, Sang FF, et al. Effect of Linggui Zhugan Decoction on levels AngⅡ、ET-1, TNF-α and IL-1β in rats with chronic heart failure [J]. Journal of Anhui Traditional Chinese Medical College, 2010, 29 (2): 53–55 (in Chinese).
 Tan SJ, Meng SY, Peng ZL. Effect of Warming Yang and Diuretic in treating chronic heart failure [J]. China Medicine, 2016, 11 (4): 485–488 (in Chinese).
 Long W. The application of computational Chinese Materia Medica to the studies of Chinese Materia Medica properties and traditional Chinese Medicine Prescriptions [D]. Beijing: Peking Union Medical College, 2011 (in Chinese).
 Liu Z, Guo F, Wang Y, et al. BATMAN-TCM: a Bioinformatics A-nalysis Tool for Molecular mechanism of Traditional Chinese Medicine [J]. Scientific Reports, 2016, 6: 21 146.
 Wu WM. Study on the chemical constituents and bioactivities of Lycoris sprengeri, Abies fargesii and Schisandra glaucescens [D]. Wuhan: Huazhong University of Science and Technology, 2016 (in Chinese).
 Hao P, Fan J, Jing C, et al. Traditional Chinese medicine for cardiovascular disease,: evidence and potential mechanisms [J]. Journal of the American College of Cardiology, 2017, 69 (24): 2 952.
 Wu DH, Qiu XH, Zhu W, et al. Study on mechanism of clearing-heat herbs on coronary disease in molecular level by network pharmacology [J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2011, 26 (5): 1 004–1 008 (in Chinese).
 Teerlink J R. Neurohumoral mechanisms in heart failure: a central role for the renin-angiotensin system [J]. Journal of Cardiovascular Pharmacology, 1996, 27 Suppl 2 (6): S1.
 Wong C, Mahapatra NR, Chitbangonsyn S, et al. The angiotensin IIreceptor (Agtr1a): functional regulatory polymorphisms in a locus genetically linked to blood pressure variation in the mouse [J]. Physiological Genomics, 2003, 14 (1): 83.
 Wasilewska A, Franciszek S?czewski, Hudson A L, et al. Fluorinated analogues of marsanidine, a highly α2-AR/imidazoline I1 binding site-selective hypotensive agent. Synthesis and biological activities [J]. European Journal of Medicinal Chemistry, 2014, 87 (87): 386–397.
 Zhao XH, Zhou Y, Wang Y, et al. 曲美他嗪联合炙甘草汤治疗老年慢性心力衰竭合并窦性心动过缓的临床研究 [J]. Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease, 2018, 16 (16): 2 358–2 360 (in Chinese).
 Wang WR. 炙甘草汤合麻黄附子细辛汤对窦性心动过缓治疗的效果研究 [J]. Journal of Clinical Medical Literature, 2017, 4 (49): 9 671–9 671 (in Chinese).
 Zheng L, Fu BZ, Xie H, et al. Effects of glycyrrhizic acid and glycyrrhetinic acid on levels of reactive oxygen species in H9C2 cell line [J]. Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease, 2016, 14 (1): 21–25 (in Chinese).
 Wan JY, Yang JH, Yu L, et al. Influence of compatibility of glycyrrhetinic acid, liqiuritin and hypaconitine on apoptosis pathway in rats with chronic heart failure [J]. Chinese Traditional Patent Medicine, 2017, 39 (10): 2 018–2 023 (in Chinese).
 Hopkins A L. Network pharmacology: the next paradigm in drug discovery [J]. Nature Chemical Biology, 2008, 4 (11): 682–690.
 Ren GM. Establishment of medicinal plant database and network pharmacology analysis based on text mining [D]. Beijing: Peking Union Medical College, 2014 (in Chinese).